AGL 8.30 Decreased By ▼ -0.03 (-0.36%)
ANL 10.95 Increased By ▲ 0.25 (2.34%)
AVN 79.70 Increased By ▲ 1.51 (1.93%)
BOP 5.75 Increased By ▲ 0.18 (3.23%)
CNERGY 5.64 Increased By ▲ 0.26 (4.83%)
EFERT 79.36 Increased By ▲ 0.71 (0.9%)
EPCL 67.48 Decreased By ▼ -0.31 (-0.46%)
FCCL 14.89 Increased By ▲ 0.39 (2.69%)
FFL 6.70 Increased By ▲ 0.10 (1.52%)
FLYNG 7.16 Increased By ▲ 0.13 (1.85%)
GGGL 11.60 Increased By ▲ 0.26 (2.29%)
GGL 17.51 Increased By ▲ 0.27 (1.57%)
GTECH 8.35 Increased By ▲ 0.05 (0.6%)
HUMNL 7.17 Increased By ▲ 0.11 (1.56%)
KEL 3.14 Increased By ▲ 0.06 (1.95%)
LOTCHEM 35.20 Increased By ▲ 2.33 (7.09%)
MLCF 28.35 Increased By ▲ 0.05 (0.18%)
OGDC 87.70 Increased By ▲ 3.15 (3.73%)
PAEL 16.63 Increased By ▲ 0.18 (1.09%)
PIBTL 6.05 Increased By ▲ 0.20 (3.42%)
PRL 19.46 Increased By ▲ 1.34 (7.4%)
SILK 1.14 No Change ▼ 0.00 (0%)
TELE 11.41 Increased By ▲ 0.31 (2.79%)
TPL 9.20 Increased By ▲ 0.20 (2.22%)
TPLP 20.25 Increased By ▲ 0.37 (1.86%)
TREET 27.10 Increased By ▲ 0.48 (1.8%)
TRG 96.20 Increased By ▲ 1.70 (1.8%)
UNITY 20.85 Increased By ▲ 0.48 (2.36%)
WAVES 13.90 Increased By ▲ 0.27 (1.98%)
WTL 1.34 Increased By ▲ 0.03 (2.29%)
BR100 4,275 Increased By 67 (1.59%)
BR30 15,794 Increased By 348.3 (2.26%)
KSE100 42,872 Increased By 628.4 (1.49%)
KSE30 16,219 Increased By 247.6 (1.55%)
Markets

Wall Street ends mixed as new aid deal remains elusive

    • Nasdaq was down 0.4 percent to 10,968.36, but the Dow Jones Industrial Average gained 1.3 percent to end at 27,791.44.
Published August 11, 2020

NEW YORK: Wall Street ended Monday's trading session the way it started: mixed, with Nasdaq retreating again as investors eye uncertain data and an elusive deal on a new emergency spending package.

At the closing bell on the first trading session of the week, the tech-rich Nasdaq was down 0.4 percent to 10,968.36, but the Dow Jones Industrial Average gained 1.3 percent to end at 27,791.44 and the broad-based S&P 500 rose 0.3 percent to finish at 3,360.47.

The only data reports released Monday both offered information on the state of the pandemic-ravaged US jobs market, but one was from June, before COVID-19 cases began to resurge, taking the total past five million.

The other, the Conference Board's Employment Trends Index, showed a slight improvement in July but nonetheless confirmed the grim outlook.

The index is down 53.8 percent from a year ago, and Gad Levanon, head of The Conference Board Labor Markets Institute, warned that in coming months "job growth will significantly put on the brakes, likely causing the national unemployment rate to remain in double-digit territory."

What form a new spending package will take remained in doubt as the White House and Democratic leaders in Congress traded barbs and blaming each other for the failure to reach agreement.

President Donald Trump signed four executive orders over the weekend including one to defer payroll taxes, and another to provide $400 in weekly unemployment benefits, $100 of which will be paid by already cash-strapped states, to replace the $600 weekly payments that expired at the end of July.

Senator Chuck Schumer, the lead Democrat in the upper house of Congress, called Trump's efforts "laughable," while Treasury Secretary Steven Mnuchin called the Democratic proposal for aid to state and local governments "absurd."

But Peter Cardillo of Spartan Capital Securities told AFP: "The market is ignoring negative factors.

"It continues to move on higher on hopes of the recovery gaining traction."

McDonald's slipped 0.2 percent after the company announced it was suing former CEO Steve Easterbrook to recover compensation after discovering he lied "and destroyed information" about relationships with three other employees, and gave stock worth hundreds of thousands of dollars to one of the employees.

Marriott International missed earnings expectations but still jumped 3.6 percent on the upbeat outlook, while MGM Resorts surged nearly 14 percent after announcing a $1 billion investment.

But Kodak plunged 28 percent after a US agency suspended a loan intended to support the former photo giant's launch of a new pharmaceutical venture following controversy that has surrounded its July 28 announcement about the $765 million loan.

Comments

Comments are closed.